Measuring plasma OPG levels could improve the ability to determine the stability of plaques in ischemic stroke patients, especially in those who present with a poor temporal window and those who cannot endure a 60-minute MES monitoring session. The gene discussed is TNFRSF11B; the disease is ischemic stroke.